Haima Therapeutics
Cleveland
About Haima Therapeutics
Haima Therapeutics is a pre-clinical stage biotechnology company. It focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. It is developing platelet-inspired therapeutics to mitigate bleeding and treat other blood-related disorders where platelets play a key role in its progressions, such as thrombosis, inflammation, and cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Last round: Grant (May 2020)
- Website: haimatherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/haima-therapeutics-90570 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.